Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors

Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors

US Patent 9782407 · Granted Oct 10, 2017

Estimated economic value: $2,883,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted cycloalkanes for managing nephrogenic diabetes insipidus2025
Substituted cycloalkanes for managing nephrogenic diabetes insipidus2025
Piperidine urea derivatives as soluble epoxide hydrolase inhibitors2024
Piperidine urea derivatives as soluble epoxide hydrolase inhibitors2024
Methods of controlling crop pests using aromatic amide insect repellents, method2024
Piperidine urea derivatives as soluble epoxide hydrolase inhibitors2024
Piperidine urea derivatives as soluble epoxide hydrolase inhibitors2024
Substituted cycloalkanes for managing nephrogenic diabetes insipidus2023
Substituted cycloalkanes for managing nephrogenic diabetes insipidus2023
Substituted cycloalkanes for managing nephrogenic diabetes insipidus2021
Substituted cycloalkanes for managing nephrogenic diabetes insipidus2021
Method of inhibiting apolipoprotein-E expression while increasing expression of 2019